4:11 PM ET
8-K
Loan & Debt
Endovia Health Sciences $500K Debt Financing with C/M Capital Master Fund, LP
Endovia Health Sciences closed an initial $500,000 tranche of secured convertible debt funding from C/M Capital Master Fund, LP. This financing is part of a larger $1 million commitment intended to accelerate the development and commercialization of CannEpil®, the company's cannabinoid-based pharmaceutical asset.
- Value
- $500K
- Counterparty
- C/M Capital Master Fund, LP